Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092773911> ?p ?o ?g. }
- W3092773911 abstract "Abstract Background Early identification of individuals at risk of dementia is mandatory to implement prevention strategies and design clinical trials that target early disease stages. Subjective cognitive decline (SCD) and neuropsychiatric symptoms (NPS) have been proposed as potential markers for early manifestation of Alzheimer’s disease (AD). We aimed to investigate the frequency of NPS in SCD, in other at-risk groups, in healthy controls (CO), and in AD patients, and to test the association of NPS with AD biomarkers, with a particular focus on cognitively unimpaired participants with or without SCD-related worries. Methods We analyzed data of n = 687 participants from the German DZNE Longitudinal Cognitive Impairment and Dementia (DELCODE) study, including the diagnostic groups SCD ( n = 242), mild cognitive impairment (MCI, n = 115), AD ( n = 77), CO ( n = 209), and first-degree relatives of AD patients (REL, n = 44). The Neuropsychiatric Inventory Questionnaire (NPI-Q), Geriatric Depression Scale (GDS-15), and Geriatric Anxiety Inventory (GAI-SF) were used to assess NPS. We examined differences of NPS frequency between diagnostic groups. Logistic regression analyses were carried out to further investigate the relationship between NPS and cerebrospinal fluid (CSF) AD biomarkers, focusing on a subsample of cognitively unimpaired participants (SCD, REL, and CO), who were further differentiated based on reported worries. Results The numbers of reported NPS, depression scores, and anxiety scores were significantly higher in subjects with SCD compared to CO. The quantity of reported NPS in subjects with SCD was lower compared to the MCI and AD group. In cognitively unimpaired subjects with worries, low Aß42 was associated with higher rates of reporting two or more NPS (OR 0.998, 95% CI 0.996–1.000, p < .05). Conclusion These findings give insight into the prevalence of NPS in different diagnostic groups, including SCD and healthy controls. NPS based on informant report seem to be associated with underlying AD pathology in cognitively unimpaired participants who worry about cognitive decline. Trial registration German Clinical Trials Register DRKS00007966 . Registered 4 May 2015." @default.
- W3092773911 created "2020-10-22" @default.
- W3092773911 creator A5002289257 @default.
- W3092773911 creator A5006279379 @default.
- W3092773911 creator A5007801159 @default.
- W3092773911 creator A5013040609 @default.
- W3092773911 creator A5015892420 @default.
- W3092773911 creator A5019564409 @default.
- W3092773911 creator A5020827587 @default.
- W3092773911 creator A5021920622 @default.
- W3092773911 creator A5026015195 @default.
- W3092773911 creator A5027958984 @default.
- W3092773911 creator A5045721609 @default.
- W3092773911 creator A5048074007 @default.
- W3092773911 creator A5048249357 @default.
- W3092773911 creator A5049386810 @default.
- W3092773911 creator A5050028517 @default.
- W3092773911 creator A5052860573 @default.
- W3092773911 creator A5055109212 @default.
- W3092773911 creator A5055216581 @default.
- W3092773911 creator A5057582966 @default.
- W3092773911 creator A5058497983 @default.
- W3092773911 creator A5058700745 @default.
- W3092773911 creator A5058720451 @default.
- W3092773911 creator A5063878047 @default.
- W3092773911 creator A5065253382 @default.
- W3092773911 creator A5069022559 @default.
- W3092773911 creator A5069247816 @default.
- W3092773911 creator A5075596948 @default.
- W3092773911 creator A5076331208 @default.
- W3092773911 creator A5076725070 @default.
- W3092773911 creator A5078440867 @default.
- W3092773911 creator A5078895221 @default.
- W3092773911 creator A5079896442 @default.
- W3092773911 creator A5080049532 @default.
- W3092773911 creator A5080610545 @default.
- W3092773911 date "2020-10-16" @default.
- W3092773911 modified "2023-10-16" @default.
- W3092773911 title "Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study" @default.
- W3092773911 cites W146699830 @default.
- W3092773911 cites W1508331658 @default.
- W3092773911 cites W1534232015 @default.
- W3092773911 cites W1544359545 @default.
- W3092773911 cites W1721452941 @default.
- W3092773911 cites W1996053420 @default.
- W3092773911 cites W2008935760 @default.
- W3092773911 cites W2013751858 @default.
- W3092773911 cites W2014743198 @default.
- W3092773911 cites W2038463584 @default.
- W3092773911 cites W2040791183 @default.
- W3092773911 cites W2043297459 @default.
- W3092773911 cites W2048505725 @default.
- W3092773911 cites W2082027882 @default.
- W3092773911 cites W2088391242 @default.
- W3092773911 cites W2103383210 @default.
- W3092773911 cites W2105121811 @default.
- W3092773911 cites W2107537187 @default.
- W3092773911 cites W2108335346 @default.
- W3092773911 cites W2115300091 @default.
- W3092773911 cites W2124878571 @default.
- W3092773911 cites W2128961718 @default.
- W3092773911 cites W2134711807 @default.
- W3092773911 cites W2143681390 @default.
- W3092773911 cites W2158415185 @default.
- W3092773911 cites W2160776412 @default.
- W3092773911 cites W2161755739 @default.
- W3092773911 cites W2167834847 @default.
- W3092773911 cites W2207877462 @default.
- W3092773911 cites W2261904358 @default.
- W3092773911 cites W2510669400 @default.
- W3092773911 cites W2570315135 @default.
- W3092773911 cites W2765663479 @default.
- W3092773911 cites W2769427583 @default.
- W3092773911 cites W2785983305 @default.
- W3092773911 cites W2798054687 @default.
- W3092773911 cites W2800499234 @default.
- W3092773911 cites W2810075348 @default.
- W3092773911 cites W2810367404 @default.
- W3092773911 cites W2904079367 @default.
- W3092773911 cites W2962854462 @default.
- W3092773911 cites W2965590124 @default.
- W3092773911 cites W2998968185 @default.
- W3092773911 cites W3015041880 @default.
- W3092773911 cites W3047873932 @default.
- W3092773911 cites W577743257 @default.
- W3092773911 doi "https://doi.org/10.1186/s13195-020-00701-7" @default.
- W3092773911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7566134" @default.
- W3092773911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33066827" @default.
- W3092773911 hasPublicationYear "2020" @default.
- W3092773911 type Work @default.
- W3092773911 sameAs 3092773911 @default.
- W3092773911 citedByCount "15" @default.
- W3092773911 countsByYear W30927739112021 @default.
- W3092773911 countsByYear W30927739112022 @default.
- W3092773911 countsByYear W30927739112023 @default.
- W3092773911 crossrefType "journal-article" @default.
- W3092773911 hasAuthorship W3092773911A5002289257 @default.
- W3092773911 hasAuthorship W3092773911A5006279379 @default.
- W3092773911 hasAuthorship W3092773911A5007801159 @default.
- W3092773911 hasAuthorship W3092773911A5013040609 @default.